|
Comparative Oncology Trials Consortium (COTC)
The Comparative Oncology Trials Consortium (COTC) is an active network of academic comparative
oncology centers, centrally managed by the NIH-National Cancer Institute's Comparative Oncology
Program, that functions to design and execute clinical trials in dogs with cancer to assess novel
therapies. The goal of this effort is to answer biological questions geared to inform the development
path of these agents for future use in human cancer patients. Trials conducted by the COTC are
pharmacokinetically and pharmacodynamically rich with the product of this work directly integrated
into the design of current human Phase I and II clinical trials. Our trials are carried at COTC
member institutions, which currently include eighteen sites.
All veterinary universities that met the established criteria have been invited to join the Comparative Oncology Trial Consortium.
Auburn University, Auburn University, AL
Colorado State University, Ft. Collins, CO
Cornell University, Ithaca, NY
Michigan State University, East Lansing, MI
North Carolina State University, Raleigh, NC
Purdue University, West Lafayette, IN
Texas A&M University, College Station, TX
The Ohio State University, Columbus, OH
Tufts University, North Grafton, MA
University of California, Davis, CA
University of Florida, Gainesville, FL
University of Georgia, Athens, GA
University of Illinois, Urbana, IL
University of Minnesota, St. Paul, MN
University Of Missouri, Columbia, MO
University Of Pennsylvania, Philadelphia, PA
University Of Tennessee, Knoxville, TN
University of Wisconsin, Madison, WI
For more information regarding the Comparative Oncology Trial Consortium, please contact Christina Mazcko at mazckoc@mail.nih.gov
|
